Alnylam sues Pfizer and Moderna claiming infringement on its delivery technology for COVID shots
Alnylam sues Pfizer and Moderna claiming infringement on its delivery [...]
BioNTech, CureVac part of $3.14B deal to bolster German vaccine capacity through 2029: report
BioNTech, CureVac part of $3.14B deal to bolster German vaccine [...]
AbbVie, Eli Lilly, Novartis and more cut back in Russia amid corporate exodus over Ukraine war
AbbVie, Eli Lilly, Novartis and more cut back in Russia [...]
Lilly and Boehringer’s Jardiance, trailing AZ’s Farxiga in chronic kidney disease, posts efficacy win
Lilly and Boehringer’s Jardiance, trailing AZ’s Farxiga in chronic kidney [...]
In rare flop, Merck calls it quits on Keytruda-Lynparza combo in prostate cancer
In rare flop, Merck calls it quits on Keytruda-Lynparza combo [...]
After trial flop, Exelixis drops plan to pair Cabometyx with Roche’s Tecentriq in early-stage liver cancer
After trial flop, Exelixis drops plan to pair Cabometyx with [...]
Indian pharma, US plastic surgeon reach deal to build $50M drug plant in Africa
Indian pharma, US plastic surgeon reach deal to build $50M [...]
Incyte’s Opzelura slapped with vitiligo delay amid topical JAK’s eczema launch
Incyte’s Opzelura slapped with vitiligo delay amid topical JAK’s eczema [...]
UsAgainstAlzheimer’s, spending millions to bat for Biogen’s Aduhelm, launches TV and digital campaign
UsAgainstAlzheimer’s, spending millions to bat for Biogen’s Aduhelm, launches TV [...]
AstraZeneca’s Fasenra hit with FDA rejection, falling further behind GSK’s Nucala in nasal polyps
AstraZeneca’s Fasenra hit with FDA rejection, falling further behind GSK’s [...]